arrow
Back
Y

Yongchang Zhang

State Administration for Market Regulation

27H-index
244Paper Count
2.9KCitation Count
Published Papers 80
Publication Date
High-dose furmonertinib as first-line treatment for untreated EGFR-mutated advanced NSCLC with central nervous system metastases: A phase 2 trial
err2026-06-30
err0
errOAAI
errHuan Yan; Wenjuan Jiang; Yi Xiong; Li Liu; Renzhi Zhang; Zhaohui Ruan; Zhe Huang; Jiacheng Dai; Fang Tian; Chunhua Zhou; Zhan Wang; Haiyan Yang; Wei Tao; Hongbo Zheng; Qinqin Xu; Nong Yang; Liang Zeng; Yongchang Zhang
errShare
errSave
Retraction Note: Time-of-day immunochemotherapy in non-small cell lung cancer: a randomized phase 3 trial
err2026-06-24
err0
PREAI
errZhe Huang; Liang Zeng; Zhaohui Ruan; Qun Zeng; Huan Yan; Wenjuan Jiang; Yi Xiong; Chunhua Zhou; Haiyan Yang; Li Liu; Jiacheng Dai; Nachuan Zou; Shidong Xu; Ya Wang; Zhan Wang; Jun Deng; Xue Chen; Jing Wang; Hua Xiang; Xiaomei Li; Boris Duchemann; Guoqiang Chen; Yang Xia; Tony Mok; Christoph Scheiermann; Francis Lévi; Nong Yang; Yongchang Zhang
errShare
errSave
Integrating single-nucleus barcoding with spatial transcriptomics via Stamp-seq to reveal immunotherapy response-enhancing functional modules in NSCLC
err2026-02-05
err0
errOAAI
errYitong Pan; Huan Yan; Jinhuan Han; Rui Wu; Caiming Xu; Guang Lei; Xingyong Ma; Ying Guan; Zhao Li; Junyuan Deng; Keyu Li; Qingquan Wei; Guangxin Zhang; Lei Liu; Ajay Goel; Zhou Yang; Shaozhuo Jiao; Yongchang Zhang; Chenxi Tian
errShare
errSave
Time-of-day immunochemotherapy in nonsmall cell lung cancer: a randomized phase 3 trial
err2026-02-02
err0
PREAI
errZhe Huang; Liang Zeng; Zhaohui Ruan; Qun Zeng; Huan Yan; Wenjuan Jiang; Yi Xiong; Chunhua Zhou; Haiyan Yang; Li Liu; Jiacheng Dai; Nachuan Zou; Shidong Xu; Ya Wang; Zhan Wang; Jun Deng; Xue Chen; Jing Wang; Hua Xiang; Xiaomei Li; Boris Duchemann; Guoqiang Chen; Yang Xia; Tony Mok; Christoph Scheiermann; Francis Lévi; Nong Yang; Yongchang Zhang
errShare
errSave
A knowledge-guided feature selection method for lung cancer immunotherapy response prediction via pathology image analysis
err2026-01-03
err0
PREAI
errXuyun Chen; Zhe Huang; Fang Tian; Renzhi Zhang; Xiaojun Zhou; Qian Gao; Yongchang Zhang
errShare
errSave
Improved Backstepping Control Strategy for Current Source Rectifier Under Nonideal Grid Conditions
err2025-12-31
err0
PREAI
errHao Ding; Yuhang Liu; Xiaoqiang Guo; Shouxiang Li; Yongchang Zhang; Zhenbin Zhang
errShare
errSave
Coordinate Transformation Based on Vector Magnetic Circuit Theory and Its Application in Sensorless Control of SPMSM
err2025-12-30
err0
PREAI
errXinkai Zhu; Changhao Song; Ming Cheng; Wei Qin; Dajun Zhao; Yongchang Zhang; Zheng Wang
errShare
errSave
Overall survival according to time-of-day of immunochemotherapy for extensive-stage small cell lung cancer
errCANCER
IF5.1
err2025-12-15
err0
PREAI
errHuang, Zhe; Ruan, Zhaohui; Xu, Shidong; Zou, Nachuan; Deng, Li; Yan, Huan; Dai, Jiacheng; Deng, Jun; Chen, Xue; Wang, Jing; Xiang, Hua; Zeng, Liang; Yin, Gang; Zhang, Yongchang
errShare
errSave
PD-1/ PD-L1 bispecific antibody IBI318 combined with lenvatinib in advanced non-small cell lung cancer with acquired resistance to immune checkpoint inhibitors: a phase II trial
err2025-12-15
err0
errOAAI
errLiang Zeng; Zhaohui Ruan; Huan Yan; Haoyue Qin; Zhen Zeng; Chun Zou; Zhe Huang; Wenjuan Jiang; Jiacheng Dai; Shidong Xu; Lianxi Song; Yangqian Chen; Yuda Zhang; Fanxu Zeng; Shiyou Wei; Shanmei Chen; Li Liu; Yi Xiong; Zhan Wang; Jun Deng; Xing Zhang; Yuanze Sun; Dan Yang; Chunhua Zhou; Haiyan Yang; Yizhi Li; Li Deng; Qinqin Xu; Chao Fang; Xue Chen; Jing Wang; Ting Li; Gao Zhang; Hui Zhou; Nong Yang; Yongchang Zhang
errShare
errSave
A translational study on the survival and molecular mechanism of PD-L1 expression in EGFR-mutant NSCLC treated with osimertinib
err2025-11-21
err0
errOAAI
errShidong Xu; Yangqian Chen; Xing Zhang; Xuexue Zhou; Jiacheng Dai; Yuanze Sun; Jie Zou; Yahui Chen; Linrui Ma; Zhe Huang; Liang Zeng; Yongchang Zhang
errShare
errSave
The evolving landscape of leptomeningeal metastases from NSCLC: an international, contemporary, multicenter cohort study
err2025-10-20
err0
errOAAI
errM.M. Zheng; Y. Xia; K. Pan; F. Sun; A. Tan; X.R. Dong; H.Y. Tu; L.B. Tang; Y.S. Li; K. Yin; M. Borgeaud; S. Singhal; E. Zhu; J. Zhang; M. Nilsson; J. Wu; D. Gibbons; H. Wakelee; J.W. Neal; J. Lee; A.A. Vaporciyan; W. Ringsurongkawong; H. Tran; R.Z. Zhang; T. Zhang; Q. Zhou; W.Z. Zhong; W. Li; Y.C. Zhang; J.W. Riess; A. Addeo; J.V. Heymach; N. Myall; D. Tan; Y.L. Wu; X. Le
errShare
errSave
Radiotherapy combined with first-line anti-programmed cell death protein 1 (PD-1) immunotherapy and chemotherapy for patients with advanced non-small cell lung cancer: A bicentric retrospective study
err2025-10-01
err0
errOAAI
errHuang, Yu; Ding, Peng; Zhang, Ruiguang; Zhang, Yongchang; Tong, Fan; Cheng, Shishi; Peng, Ling; Jie, Xiaohua; Wang, Jian; Liu, Pian; Zhang, Sheng; Wu, Gang; Yang, Nong; Dong, Xiaorong
errShare
errSave
Sacituzumab Tirumotecan in EGFR-TKI-Resistant, EGFR-Mutated Advanced NSCLC
err2025-10-01
err8
PREAI
errFang, Wenfeng; Wu, Lin; Meng, Xiangjiao; Yao, Yu; Zuo, Wei; Yao, Wenxiu; Xie, Yanyan; Zhang, Yu; Cui, Jiuwei; Zhang, Yongchang; Li, Xingya; Zhuang, Wu; Fang, Jian; Wang, Qiming; Jiang, Wei; Li, Kai; Bai, Yuju; Luo, Yongzhong; Ma, Fang; Yu, Yan; Zheng, Wei; Liu, Zhentian; Yang, Bin; Ma, Rui; Fang, Yong; Yang, Runxiang; Jiang, Liyan; Hu, Jie; Yang, Jiacheng; Diao, Yina; Jin, Xiaoping; Ge, Junyou; Yang, Yunpeng; Zhang, Li
errShare
errSave
Homaliodendron maolanense sp. nov. (Neckeraceae, Bryophyta), a new species from China based on molecular and morphological data
err2025-09-26
err0
PREAI
errYang, Jun; Lei, Fumin; Huang, Ruoling; Zhang, Yongchang; He, Lin; Guo, Shuiliang; Yu, Jing; Li, Dandan
errShare
errSave
Prognostic implications of uncommon EGFR exon 19 deletion-insertion mutations in non-small cell lung cancer treated with third-generation EGFR-TKIs
err2025-09-15
err0
PREAI
errRenzhi Zhang; Huan Yan; Fang Tian; Yun Jiang; Yangqian Chen; Jiao Huang; Zhaohui Ruan; Shidong Xu; Zhe Huang; Qinqin Xu; Liang Zeng; Yongchang Zhang
errShare
errSave
Comprehensive first-in-human phase I/II study of FHND-9041 in patients with EGFR-mutated advanced non-small cell lung cancer
err2025-07-31
err0
PREAI
errLiang Zeng; Fan Tong; Xingxiang Xu; Lianxi Song; Shidong Xu; Jie Zou; Bo Qiu; Weidong Mao; Hailong Liu; Bing Zhang; Feng Rong; Jun Sun; Hua Xie; Yongqian Jiang; Wenjuan Jiang; Zhan Wang; Sheng Zhang; Ruiguang Zhang; Lingjuan Chen; Yongqiang Zhu; Minghong Shang; Rongzhen Chen; Gao Zhang; Ting Li; Fuyan Wang; Xiaorong Dong; Nong Yang; Yongchang Zhang
errShare
errSave
Lymphocyte subset-based non-invasive biomarker predicts immunochemotherapy efficacy in EGFR-TKI-pretreated EGFR-mutated NSCLC
err2025-07-25
err0
errOAAI
errLianxi Song; Liang Zeng; Qinqin Xu; Yizhi Li; Wenhuan Guo; Shaoding Lin; Wenjuan Jiang; Zhan Wang; Li Deng; Zhe Huang; Haoyue Qin; Huan Yan; Xing Zhang; Fan Tong; Ruiguang Zhang; Zhaoyi Liu; Lin Zhang; Juan Yu; Xue Yang; Yang Xia; Xiaorong Dong; Gao Zhang; Nong Yang; Yongchang Zhang
errShare
errSave
Clinical Outcomes of Patients with Advanced ALK-rearranged Lung Squamous Cell Carcinoma Treated with ALK Tyrosine Kinase Inhibitors
err2025-07-19
err0
PREAI
errYuanze Sun; Dan Yang; Zhe Huang; Huan Yan; Liang Zeng; Qinqin Xu; Lianxi Song; Chunhua Zhou; Ling Peng; Jiwen Xiao; Shaoding Lin; Zhiqing Zhou; Siqi Xiang; Zhaohui Ruan; Nong Yang; Yongchang Zhang
errShare
errSave
Author Correction: Spatial immune scoring system predicts hepatocellular carcinoma recurrence
errNature
IF48.5
err2025-07-10
err0
PREAI
errGengjie Jia; Peiqi He; Tianli Dai; Denise Goh; Jiabei Wang; Mengyuan Sun; Felicia Wee; Fuling Li; Jeffrey Chun Tatt Lim; Shuxia Hao; Yao Liu; Tony Kiat Hon Lim; Nye-Thane Ngo; Qingping Tao; Wei Wang; Ahitsham Umar; Björn Nashan; Yongchang Zhang; Chen Ding; Joe Yeong; Lianxin Liu; Cheng Sun
errShare
errSave